Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02560883 · ClinicalTrials.gov registry record
Hairy Cell Leukemia Patient Data Registry
A clinical trial of Leukemia, Other, sponsored by Ohio State University Comprehensive Cancer Center.
- Recruiting
- Registry status
- 5,000
- Enrollment target
- 6
- Study locations
NCT02560883: Recruiting study of Leukemia, Other, sponsored by Ohio State University Comprehensive Cancer Center.
NCT02560883 is a study of Leukemia, Other that is actively recruiting participants, run by Ohio State University Comprehensive Cancer Center. The registered enrollment target is 5,000 participants. The trial reports 6 study locations across 6 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02560883, a study of Leukemia, Other, is actively recruiting participants, sponsored by Ohio State University Comprehensive Cancer Center.
- RECRUITING
- Registry status
- 5,000 participants
- Enrollment target
- 6
- Study locations
Study Summary
The overall objective is to develop a clinical data registry that can be used to facilitate research with the ultimate goal of reducing the morbidity and/or mortality and improving the quality of life of patients diagnosed or living with hairy cell leukemia. With approximately 1,000 new cases of this rare disease identified in the US each year, HCL represents 2% of all cases of leukemia in adults. Considering the rarity of this chronic leukemia, the Hairy Cell Leukemia Foundation (HCLF), in partnership with investigators from its Centers of Excellence, seeks to develop a registry to help researchers identify new trends in outcomes, recognize the most effective treatments, discover previously unknown complications of the disease, and design clinical trials for new therapies.
Primary Outcome
Establish a database of Hairy Cell Leukemia patients diagnosed or living in US to track Hairy Cell Leukemia disease course, patient reported outcomes, morbidity, and patient survival.
Conditions Studied
Study Locations (6)
Florida
- University of Miami/Soffer Clinical Research Center - Miami
Minnesota
- Mayo Clinic - Rochester
New York
- University of Rochester /Wilmot Cancer Institute - Rochester
Ohio
- Ohio State University Comprehensive Cancer Center - Columbus
Victoria
- Peter MacCallum Cancer Center - Melbourne
Manitoba
- Cancer Care Manitoba - Winnipeg
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5,000 participants |
| Start Date | 2013-01-02 |
| Est. Completion | 2030-12-31 |
What NCT02560883 shows while recruiting
NCT02560883 is an observational study that tracks outcomes without assigning an intervention. Its 5,000 participants enrollment target places it among the larger protocols in the corpus.
The record links to 1 condition, with Leukemia, Other appearing as the primary indexed condition, and to 0 interventions.
NCT02560883 lists 6 locations in 6 states (Florida, Minnesota, New York).
Frequently Asked Questions
What is clinical trial NCT02560883 about?
NCT02560883 is a clinical study titled "Hairy Cell Leukemia Patient Data Registry". The overall objective is to develop a clinical data registry that can be used to facilitate research with the ultimate goal of reducing the morbidity and/or mortality and improving the quality of life of patients diagnosed or living with hairy cell leukemia. With approximately 1,000 new cases of thi...
What is the current status of trial NCT02560883?
This trial is currently recruiting. The enrollment target is 5,000 participants. The study started on 2013-01-02. Estimated completion is 2030-12-31.
What conditions does trial NCT02560883 study?
This clinical trial studies the following conditions: Leukemia, Other.
Who is sponsoring clinical trial NCT02560883?
This trial is sponsored by Ohio State University Comprehensive Cancer Center, which has 341 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02560883 being conducted?
This trial has 6 study locations across Florida, Minnesota, New York, Ohio, Victoria. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Leukemia, Other
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00060541 · 5,000 participants
Evaluation and Treatment of Neurosurgical Disorders
- NCT00575081 · 5,000 participants
Physiological Brain Atlas Development
- NCT00736749 · 5,000 participants
Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies
- NCT00900198 · 5,000 participants
Collection of Tissue Samples for Cancer Research
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI